DOING an extra five minutes of exercise daily could help lower the ris...

By Anne Lepesant on SwimSwamFitter and Faster Swim Camps is the proud sponsor of SwimSwam’s College Recruiting Channel and all commitment n...

It’s vaccination season, which for most people means getting immunized for flu and COVID-19 (and RSV for infants, pregnant women, or...

SOCCCD Communications The South Orange County Community College District showed a $7.1 billion impact on the Orange County economy, accordin...

Kamala Harris lost in the state of Missouri on Tuesday, keeping with the expected results from polls prior to Election Day. But three progre...

Cats are quicker than babies to associate a picture of a word with its corresponding picture, new research sho...

Patients with cancer receiving immune checkpoint inhibitors had a twofold higher risk of developing psoriasis than those receiving chemother...

Hamas leader Yahya Sinwar was killed by a group of Israeli trainee soldiers in Tal as-Sultan, Rafah, last month. It was a fateful and une...

California voters on Tuesday approved a ballot measure seeking harsher punishment for retail crimes including shoplifting and theft.R...

The implementation of Fortinet solutions marked a transformative phase for AlSafy Group. The deployment of FortiGate firewalls significantly...

AI in Fashion Market Advance Market Analytics published a new research publication on “AI in Fashion Market Insights, to 2030” with 232 page...

Positive End of Phase 2 discussion with FDA, including alignment on Phase 3 design Bayley-4 expressive communication selected as Phase 3 stu...

A diverse, real-world patient population with triple-negative breast cancer that received pembrolizumab showed similar overall rates of immu...

A global study has revealed how extreme precipitation events are linked to higher mortality rates, particularly from respiratory and cardiov...

Positive results of a phase 2 study support the potential to repurpose intranasal insulin and the SGLT2 inhibitor empagliflozin for Alzheime...